Morgan Stanley Maintains Equal-Weight on Verizon Communications, Raises Price Target to $52...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Coca-Cola Q2 Preview: Stock Near All-Time Highs, Will Outperformance Vs. Pepsi Continue?...
TD Cowen Maintains Buy on Verizon Communications, Raises Price Target to $56...
Edible Garden Grows Walmart Footprint...
Why Is Salesforce Stock Surging Monday?...
4 Health Care Stocks Whale Activity In Today’s Session...
Shares of software companies are trading higher amid a rebound following IBM's profit warning last week, aided by positive SAP and ServiceNow earnings...
Mizuho Maintains Outperform on Honeywell Intl, Raises Price Target to $265...
UBS Maintains Buy on McDonald's, Lowers Price Target to $340...
UBS Maintains Buy on Microsoft, Lowers Price Target to $480...
China's $500B Memory Giant Isn't Chasing Nvidia. It's Betting on Intel and AMD...
EXCLUSIVE: Anthropic Is a ‘Generational Company,’ Tema CEO Says — and Why LAZR Made It the Top Holding Before IPO...
Adobe Stock Climbs Post-IBM Warning, ServiceNow Boost...
Aggressive Buying On Nvidia Backing Massive OpenAI Data Center And Trump Pausing Iran Attacks...
Coca-Cola's Earnings Could Put $10.7 Billion In Market Value On The Line...
This Congressman Slammed Elon Musk — Then Bought SpaceX Stock...
'The World's Most Powerful Network': X Money Rolls Out, Challenging Venmo, Robinhood, Apple Pay...
Nvidia Funds AI Frenzy: Timeline of its Circular Financing Deals ... So Far...
Alembic Pharmaceuticals Inc. received FDA approval for its 6 mg prucalopride succinate tablets (ANDA 219234) on July 27, 2026, reportedly entering the...
**LUPIN** announced today that it received final approval from the U.S. FDA for a new anda, entering the market for a generic with a specific launch d...